Articles & Other Resources

Drug maker stopped making popular antibiotic Levaquin amid concerns about mental health side effects (WRTV Indianapolis)

The makers of a popular antibiotic have halted production on the drug amid safety concerns.

Janssen pharmaceutical companies of Johnson & Johnson discontinued production of Levaquin in December 2017, including the oral and IV versions.

Andy MilesJuly 17, 2018

FDA Briefing Document: Joint Meeting of the Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

Andy MilesNovember 5, 2015

Joint Meeting of the FDA's Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee November 5, 2015

Andy MilesNovember 5, 2015

Fluoroquinolone-induced serious, persistent, multisymptom adverse effects

Andy MilesOctober 5, 2015

Our prescription drugs kill us in large numbers

Our prescription drugs are the third leading cause of death after heart disease and cancer in the United States and Europe. Around half of those who die have taken their drugs correctly; the other half die because of errors, such as too high a dose or use of a drug despite contraindications. Our drug agencies are not particularly helpful, as they rely on fake fixes

Andy MilesOctober 13, 2014

New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages

Few people know that new prescription drugs have a 1 in 5 chance of causing serious reactions after they have been approved. That is why expert physicians recommend not taking new drugs for at least five years unless patients have first tried better-established options, and have the need to do so.

© 2022 know risks

GET IN TOUCH